logo

For the Inventor, By the Inventor

Paris, France

Denis S Barritault

This inventor holds 17 USPTO granted patents and 6 published patent applications, primarily in Biocompatible Polymers. Top assignees: Centre National De La Recherche Scientifique, National Institute of Health and Medical Research, Societe Valbiofrance. Active years: 1984-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Denis S Barritault. Retrieved from https://idiyas.com/inventor/denis-s-barritault

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 

% Patents Active = 76.5

Average Co-Inventor Count = 2.7

ph-index = 7

Forward Citations = 120(Granted Patents)


Company Filing History:

goldMedal3 out of 5,383 
 
Centre National De La Recherche Scientifique
 patents
silverMedal3 out of 1,853 
 
National Institute of Health and Medical Research
 patents
bronzeMedal2 out of 2 
 
Societe Valbiofrance
 patents
4. 1 out of 1 
 
Organes Tissus Regeneration Reparation Remplacement - Otr3
 patent
5. 1 out of 1 
 
Organes Tissus Regeneration Reparation Replacement—otr3
 patent
6. 1 out of 2 
 
Therapeutiques Substitutives
 patents
7. 1 out of 1 
 
Valbiofrance
 patent
8. 7 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1984-2022

Loading Chart...
Areas of Expertise:
Tissue Lesions
Biocompatible Polymers
Angiogenesis
Cytokines
Tissue Regeneration
Nervous System
Growth Factors
Functionalized Dextrans
Epidermal Cells
Corneal Epithelium
Pharmaceutical Composition
Cosmetic Compositions
17 patents (USPTO):Explore Patents
1. 11351190 - Composition for treating tissue lesions (2022-06-07),
2. 8883715 - Biocompatible polymers, process for their preparation and compositions containing them (2014-11-11),
3. 8790631 - Use of biocompatible polymers for the preparation of a composition or a medical device (2014-07-29),
4. 8476220 - Biocompatible polymers, process for their preparation and compositions containing them (2013-07-02),
5. 7998922 - Process for treating fibroses with biocompatible polymer (2011-08-16),
6. 7534436 - Peptide fragments of the harp factor inhibiting angiogenesis (2009-05-19),
7. 6932973 - Peptides which stimulate the expression of the cytokines of inflammation and promote tissue regeneration (2005-08-23),
8. 6689741 - Biocompatible polymers, process for their preparation and compositions containing them (2004-02-10),
9. 6573251 - Drug and pharmaceutical composition for the treatment of lesions of the nervous system and fractions enriched in heparan sulfate (2003-06-03),
10. 6103880 - HARP family growth factors (2000-08-15),
11. 5852004 - Drug and pharmaceutical composition for the treatment of lesions of the (1998-12-22),
12. 5852003 - Drug and pharmaceutical composition for the treatment of muscles (1998-12-22),
13. 5693625 - Method of regenerating cells and tissues using functionalized dextrans (1997-12-02),
14. 5122597 - Application of resins consisting of functional polymers as the (1992-06-16),
15. 4670257 - Cosmetic compositions containing retinal extracts for increasing (1987-06-02),

Title: Denis S Barritault: Innovator in Biocompatible Polymers

Introduction

Denis S Barritault is a prominent inventor based in Paris, France. He has made significant contributions to the field of biocompatible polymers, holding a total of 17 patents. His work focuses on developing pharmaceutical compositions for the treatment of tissue lesions and fibroses.

Latest Patents

Barritault's latest patents include a composition for treating tissue lesions. This innovative pharmaceutical composition combines a biocompatible polymer with a eukaryotic cell, a platelet extract and/or lysate, or a growth factor. It is designed to be used as a drug for the prevention and treatment of tissue lesions. Additionally, he has developed a pharmaceutical kit that includes a biocompatible polymer in association with a eukaryotic cell for similar therapeutic purposes. His work also encompasses a process for treating fibroses, which involves administering a therapeutically effective amount of a pharmaceutical composition containing a specific biocompatible polymer.

Career Highlights

Throughout his career, Denis S Barritault has worked with notable institutions, including the National Institute of Health and Medical Research (Institut National De La Santé Et De La Recherche Médicale). His research has significantly advanced the understanding and application of biocompatible polymers in medical treatments.

Collaborations

Barritault has collaborated with esteemed colleagues such as Jean-Pierre Caruelle and Jose P Courty. These partnerships have further enriched his research and innovation in the field.

Conclusion

Denis S Barritault is a distinguished inventor whose work in biocompatible polymers has the potential to transform medical treatments for tissue lesions and fibroses. His contributions continue to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…